{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:42:26Z","timestamp":1761986546353,"version":"3.41.2"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01954","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T13:17:08Z","timestamp":1601385428000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Asymptomatic Infant With Atypical SCID and Novel Hypomorphic RAG Variant Identified by Newborn Screening: A Diagnostic and Treatment Dilemma"],"prefix":"10.3389","volume":"11","author":[{"given":"Maria","family":"Chitty-Lopez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Westermann-Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boglarka","family":"Ujhazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krisztian","family":"Csomos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry","family":"Dobbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khuong","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir A.","family":"Sadighi Akha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Chellapandian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Oshrine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi D.","family":"Notarangelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gauri","family":"Sunkersett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer W.","family":"Leiding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolan E.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1007\/s10875-013-9917-y","article-title":"The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901","volume":"33","author":"Dvorak","year":"2013","journal-title":"J Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000-2009","volume":"371","author":"Pai","year":"2014","journal-title":"New Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.bbmt.2017.04.026","article-title":"Recommendations for screening management of late effects in patients with severe combined immunodeficiency after allogenic hematopoietic cell transplantation: a consensus statement from the second pediatric blood marrow transplant consortium international conference on late effects after pediatric HCT","volume":"23","author":"Heimall","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1182\/blood-2017-05-781849","article-title":"Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study","volume":"130","author":"Heimall","year":"2017","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1182\/blood-2018-03-840702","article-title":"SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery","volume":"132","author":"Haddad","year":"2018","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10875-014-0006-7","article-title":"Newborn screening for SCID in New York State: experience from the first two years","volume":"34","author":"Vogel","year":"2014","journal-title":"J Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jaip.2016.09.028","article-title":"Profound T-cell lymphopenia associated with prenatal exposure to purine antagonists detected by TREC newborn screening","volume":"5","author":"Kuo","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.anai.2019.08.006","article-title":"Identification of nonand#x2013;severe combined immune deficiency T-cell lymphopenia at newborn screening for severe combined immune deficiency","volume":"123","author":"Kobrynski","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.jaci.2013.09.044","article-title":"Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience","volume":"133","author":"Shearer","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1056\/NEJMoa073966","article-title":"An immunodeficiency disease with RAG mutations and granulomas","volume":"358","author":"Schuetz","year":"2008","journal-title":"New Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1182\/blood-2010-02-267583","article-title":"Hypomorphic Rag mutations can cause destructive midline granulomatous disease","volume":"116","author":"De Ravin","year":"2010","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1172\/JCI80477","article-title":"Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency","volume":"125","author":"Walter","year":"2015","journal-title":"J Clin Invest"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.jaip.2019.02.038","article-title":"Outcomes and treatment strategies for autoimmunity and hyperinflammation in patients with RAG deficiency","volume":"7","author":"Farmer","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1016\/j.jaci.2018.02.007","article-title":"Prevalence and clinical challenges among adults with primary immunodeficiency and recombination-activating gene deficiency","volume":"141","author":"Lawless","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1182\/blood.V97.1.81","article-title":"V (D) J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations","volume":"97","author":"Villa","year":"2001","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"8332","DOI":"10.4049\/jimmunol.179.12.8332","article-title":"Biochemical and folding defects in a RAG1 variant associated with Omenn syndrome","volume":"179","author":"Simkus","year":"2007","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.jaci.2013.10.007","article-title":"A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency","volume":"133","author":"Lee","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.jaci.2013.11.028","article-title":"Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes","volume":"133","author":"IJspeert","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jaci.2018.05.028","article-title":"PROMIDIS\u03b1: A T-cell receptor alpha signature associated with immunodeficiencies caused by V (D) J recombination defects","volume":"143","author":"Berland","year":"2019","journal-title":"J Allergy Clin Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.jaip.2018.01.015","article-title":"Partial RAG deficiency in a patient with varicella infection, autoimmune cytopenia, anticytokine antibodies","volume":"6","author":"Goda","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.17056.1","article-title":"Recent advances in understanding RAG deficiencies","volume":"8","author":"Gennery","year":"2019","journal-title":"F1000Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0140-6736(13)62069-3","article-title":"Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study","volume":"383","author":"Gungor","year":"2014","journal-title":"Lancet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10875-017-0465-8","article-title":"The 2017 IUIS phenotypic classification for primary immunodeficiencies","volume":"38","author":"Bousfiha","year":"2018","journal-title":"J Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","article-title":"The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity","volume":"7","author":"Seidel","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B26","doi-asserted-by":"publisher","first-page":"eaah6109","DOI":"10.1126\/sciimmunol.aah6109","article-title":"Characterization of T and B cell repertoire diversity in patients with RAG deficiency","volume":"1","author":"Lee","year":"2016","journal-title":"Sci Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1080\/1744666X.2020.1670060","article-title":"Approaches to patients with variants in RAG genes: from diagnosis to timely treatment","volume":"15","author":"Bulkhi","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s10875-015-0207-8","article-title":"Late onset hypomorphic RAG2 deficiency presentation with fatal vaccine-strain VZV infection","volume":"35","author":"Dutmer","year":"2015","journal-title":"J Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"AB116","DOI":"10.1016\/j.jaci.2018.12.353","article-title":"Vasculitis as a major morbidity factor in patients with hypomorphic RAG mutations","volume":"143","author":"Geier","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.jaci.2013.10.021","article-title":"Lesson from hypomorphic recombination-activating gene (RAG) mutations: why asymptomatic siblings should also be tested","volume":"133","author":"Schuetz","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jaci.2012.04.029","article-title":"Defining combined immunodeficiency","volume":"130","author":"Roifman","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10875-020-00763-0","article-title":"Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J Clin Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10875-016-0326-x","article-title":"Unrelated hematopoietic cell transplantation in a patient with combined immunodeficiency with granulomatous disease and autoimmunity secondary to RAG deficiency","volume":"36","author":"John","year":"2016","journal-title":"J Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1391302","DOI":"10.1016\/j.jaci.2016.07.040","article-title":"A prospective study on the natural history of patients with profound combined immunodeficiency: an interim analysis","author":"Speckmann","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1007\/s10875-018-0537-4","article-title":"RAG deficiency: two genes, many diseases","volume":"38","author":"Delmonte","year":"2018","journal-title":"J Clin Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.clim.2017.10.012","article-title":"RAG deficiency with ALPS features successfully treated with TCR\u03b1\u03b2\/CD19 cell depleted haploidentical stem cell transplant","volume":"187","author":"Westermann-Clark","year":"2018","journal-title":"Clin Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fped.2019.00295","article-title":"Hematopoietic stem cell transplantation in primary immunodeficiency diseases: current status and future perspectives","volume":"7","author":"Castagnoli","year":"2019","journal-title":"Front Pediatr"},{"key":"B38","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3389\/fimmu.2017.00798","article-title":"Natural killer cells from patients with recombinase-activating gene and non-homologous end joining gene defects comprise a higher frequency of CD56 (bright) NKG2A(+++) cells, and yet display increased degranulation and higher perforin content","volume":"8","author":"Dobbs","year":"2017","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01954\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T13:17:15Z","timestamp":1601385435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01954\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2020.01954"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01954","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2020,9,29]]},"article-number":"1954"}}